Le Lézard
Classified in: Health
Subject: LAW

Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose


SAN FRANCISCO, April 15, 2024 /PRNewswire/ -- 

LEGAL NOTICE

Third-Party Payors: If you paid or reimbursed costs for prescription opioids, or paid or incurred costs for treatment related to opioid misuse, addiction, and/or overdose,

You Could Get Money from a Settlement.

Your rights may be affected by the proposed Settlement in a class action lawsuit with McKinsey & Company, Inc. ("McKinsey").  The lawsuit claims McKinsey played a central role in the opioid crisis by advising multiple opioid manufacturers and other industry participants on how to sell as many prescription opioids as possible.  McKinsey denies any wrongdoing. 

Am I included?  You may be included if you are an entity that paid and/or reimbursed for (a) opioid prescription drugs manufactured, marketed, sold, or distributed by the Opioid Marketing Enterprise Members (Purdue, Johnson & Johnson, Janssen, Cephalon, Endo, and Mallinckrodt), for purposes other than resale, and/or (b) paid or incurred costs for treatment related to the misuse, addiction, and/or overdose of opioid drugs, on behalf of individual beneficiaries, insureds, and/or members, during the period June 1, 2009 to October 31, 2023.  For clarity, included are: (a) private contractors of Federal Health Employee Benefits plans, (b) plans for self-insured local governmental entities that have not settled claims in MDL 2804, (c) managed Medicaid plans, (d) plans operating under Medicare Part C and/or D, and (e) Taft Hartley plans.  A more detailed notice, including the full class definition and who is not included, is available at www.McKinseyTPPSettlement.com.

What does the Settlement provide?  A $78 million Settlement Fund will pay money to eligible Class Members, notice and administration costs up to $1 million, and attorneys' fees, costs, and expenses. 

How can I get a payment?  Submit a claim form online or by mail postmarked by September 18, 2024.  If your claim is valid, you will get money from the Settlement.  The amount of your payment will be calculated based on the Proposed Plan of Allocation available at www.McKinseyTPPSettlement.com.  Detailed instructions about how to submit a claim are also available at www.McKinseyTPPSettlement.com.

What are my rights?  Even if you do nothing, you will be bound by the Court's decisions.  If you want to keep your right to sue McKinsey yourself, you must exclude yourself from the Settlement by June 1, 2024.  If you do not exclude yourself, you may object to the Settlement by June 1, 2024.  The Court will hold a hearing on July 26, 2024 at 10:00 a.m. to consider whether to approve the Settlement and a request for attorneys' fees not to exceed 20% of the Settlement Fund, plus litigation expenses and service awards to Class Representatives.  You or your own lawyer may appear and speak at the hearing at your own expense.  The Court may change these deadlines or the hearing date (and time).  Check the website below for updates.

For more information:  1-877-933-3322 or visit www.McKinseyTPPSettlement.com

Source:
Lieff Cabraser Heimann & Bernstein LLP

SOURCE Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC


These press releases may also interest you

at 05:30
Provisio Medical, Inc. today announced the formation of a Physician Advisory Board (PAB) comprising a multidisciplinary group of physicians who will provide input and feedback on product development decisions, outcome- focused clinical studies and...

at 05:00
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well...

at 04:21
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...



News published on and distributed by: